Clinical Manifestations and Natural History of Hodgkin's Lymphoma

被引:31
作者
Connors, Joseph M. [1 ,2 ]
机构
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Dept Med, Div Med Oncol, Vancouver, BC, Canada
关键词
Hodgkin's lymphoma; lymphoma; lymphadenopathy; paraneoplastic syndrome; pattern of spread; late complication; late toxicity; PARANEOPLASTIC CEREBELLAR DEGENERATION; ELDERLY-PATIENTS; GLOMERULAR-LESIONS; NEPHROTIC SYNDROME; DISEASE; HIV; PREDOMINANT; THERAPY; IMMUNODEFICIENCY; CHEMOTHERAPY;
D O I
10.1097/PPO.0b013e3181a282d8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hodgkin's lymphoma usually presents with typical lymphadenopathy that has been detected either incidentally by the patient or by imaging procedures performed for assessment of other conditions. Occasionally, it may be detected when investigation of nonspecific symptoms, such as fever, fatigue, or unexplained pain prompt assessment that, in turn reveals a mass lesion. The diagnosis must be confirmed with an appropriate biopsy. Nowadays, clinicians usually have little difficulty making the diagnosis of Hodgkin's lymphoma. Knowledge of the usual pattern of spread of this lymphoma, with its orderly progression through lymph node groups and its typical forms of extranodal involvement, facilitates timely diagnosis, staging, and treatment planning. Rare manifestations due to involvement of unusual sites or presentation with paraneoplastic organ dysfunction can prove challenging but a search for mass lesions and an appreciation of these uncommonly encountered findings as potential clues to the presence of Hodgkin's lymphoma usually prompts appropriate investigation and correct diagnosis. Finally, an understanding of the usual pattern and timing of relapse and knowledge of the typical types of late toxicity expected after successful eradication of the lymphoma allow the patient's physicians to detect recurrence in a timely fashion and to identify or prevent secondary complications enabling appropriate management plans to be developed.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 60 条
[1]   Long-term cause-specific mortality of patients treated for Hodgkin's disease [J].
Aleman, BMP ;
van den Belt-Dusebout, AW ;
Klokman, WJ ;
van't Veer, MB ;
Bartelink, H ;
van Leeuwen, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3431-3439
[2]  
Anagnostopoulos I, 2000, BLOOD, V96, P1889
[3]   A mouse model of allogeneic corneal endothelial cell transplantation [J].
Hayashi, Takahiko ;
Yamagami, Satoru ;
Tanaka, Kazumi ;
Yokoo, Seiichi ;
Usui, Tomohiko ;
Amano, Shiro ;
Mizuki, Nobuhisa .
CORNEA, 2008, 27 (06) :699-705
[4]   IgA nephropathy and Hodgkin's disease: A rare coincidence. Case report and literature review [J].
Bergmann, J ;
Buchheidt, D ;
Waldherr, R ;
Maywald, O ;
van der Woude, FJ ;
Hehlmann, R ;
Braun, C .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :E16-E19
[5]  
BICHEL J, 1972, LANCET, V1, P1069
[6]  
Bierman PJ, 2007, HODGKIN LYMPHOMA, P411
[7]   Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS [J].
Biggar, Robert J. ;
Jaffe, Elaine S. ;
Goedert, James J. ;
Chaturvedi, Anil ;
Pfeiffer, Ruth ;
Engels, Eric A. .
BLOOD, 2006, 108 (12) :3786-3791
[8]   LATE RELAPSE IN EARLY-STAGE HODGKINS-DISEASE PATIENTS ENROLLED ON EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PROTOCOLS [J].
BODIS, S ;
HENRYAMAR, M ;
BOSQ, J ;
BURGERS, JMV ;
MELLINK, WAM ;
DIETRICH, PY ;
DUPOUY, N ;
NOORDIJK, EM ;
RAEMAEKERS, JMM ;
THOMAS, J ;
EGHBALI, H ;
REGNIER, R ;
TANGUY, A ;
VEDONCK, L ;
MICHEL, J ;
ZITTOUN, R ;
KERKHOFS, H ;
HAYAT, M .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :225-232
[9]   Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease [J].
Bodis, S ;
Kraus, MD ;
Pinkus, G ;
Silver, B ;
Kadin, ME ;
Canellos, GP ;
Shulman, LN ;
Tarbell, NJ ;
Mauch, PM .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) :3060-3066
[10]  
CARBONE PP, 1971, CANCER RES, V31, P1860